The determination of the Interventional Radiology Products Market Size is a reflection of the cumulative value of both capital equipment sales and high-volume, disposable consumables. The size is directly influenced by two main factors: the increasing number of diagnostic and therapeutic IR procedures performed globally, and the rising average selling price of highly specialized, advanced devices (e.g., drug-eluting stents, complex ablation probes). As IR continues to replace traditional surgical procedures, the market size expands not just by volume but by capturing expenditure that was previously allocated to open surgery.

The total market size is substantial and expected to grow significantly as more procedures shift to outpatient settings, which generally increases total case volumes, and as key product segments, such as embolization devices for tumor treatment, see increased clinical uptake.